Drugs / Clomiphene Citrate
last change Sep 2026 re-read 9 days ago

Clomiphene Citrate

Other / unclassified

Developed for
polycystic ovary syndrome · infertility disorder · anovulation · female infertility · male infertility · hypogonadism, male · hypogonadotropic hypogonadism · ovarian dysfunction
+16 more · ovarian hyperstimulation syndrome · pregnancy disorder · spermatogenic failure · acromegaly · hyperprolactinemia · hypogonadism · menstrual disorder · oligoasthenoteratozoospermia · prolactin-producing pituitary gland adenoma · rotator cuff syndrome · substance-related disorder · azoospermia · endometriosis · female reproductive system disorder · obesity disorder · ovarian disorder
Investigated by
Ain Shams University · Mansoura University · Ain Shams Maternity Hospital · Assiut University · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · National Center for Research Resources (NCRR)
+71 more · Rachel Mejia · University Magna Graecia · University of Illinois at Chicago · University of Sao Paulo · University of Virginia · Weill Medical College of Cornell University · Yazd Research & Clinical Center for Infertility · Ahmed Fathy Ali Mohamed Ghanem · Al-Thawra Modern General Hospital · Albany Medical College · American Diabetes Association · American Society for Reproductive Medicine · American University of Beirut Medical Center · Auckland Medical Research Foundation · Beijing Fengtai Hospital of Integrated Traditional and Western Medicine · Beijing First Hospital of integrated Chinese and Western Medicine · Beijing Hospital of Traditional Chinese Medicine · Beijing Obstetrics and Gynecology Hospital · Benha University · Bioroma · Dongzhimen Hospital, Beijing · Eugin · Federal University of São Paulo · Felipe Henning Gaia Duarte · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Fundacion Dexeus · HITEC-Institute of Medical Sciences · Hamad Medical Corporation · Hospices Civils de Lyon · IRCCS San Raffaele · Ibn Sina Hospital · Istituti Clinici Zucchi · Istituto Clinico Humanitas · Johns Hopkins University · Kufa University · Laboratory Corporation of America · Laylay Mohammed Khalleefah Alhibshi · Mansoura Integrated Fertility Center · Mayo Clinic · Menoufia Obstetrics and Gynecology Group · Mercia Barnes Trust of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists · Milton S. Hershey Medical Center · Navy General Hospital, Beijing · Nova Clinic, Russia · Partnership for Clean Competition · RenJi Hospital · Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) · Royan Institute · Sana'a University · Semnan University of Medical Sciences · Shaare Zedek Medical Center · Shakeela Ishrat · ShangHai Ji Ai Genetics & IVF Institute · Sheba Medical Center · Society for Reproductive Investigation · Sports Medicine Research and Testing Laboratory · State University of New York at Buffalo · Stuart Willick · Szeged University · The Egyptian IVF-ET Center · The University of Hong Kong · University Hospitals Cleveland Medical Center · University of Auckland, New Zealand · University of Chicago · University of Oklahoma · University of Southern California · University of Utah · University of Wisconsin, Madison · Xiyuan Hospital of China Academy of Chinese Medical Sciences · Yale University · Yazd Medical University

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) CLOMID — 1967-02-01 fda.gov ↗

Trials 66 · started per year

today
US approved 1967
1
2
1
2
1
1
1
1
3
3
4
2
2
2
4
9
2
4
3
4
2
2
2
3
2
1
2
1966196719681969197019711972197319741975197619771978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT04361175 Mar → Sep 2021 infertility disorder Assiut University Unknown No outcome recorded
Phase 16 trials · 1 missed
Phase 1 NCT06813118 Jun 2024 → Mar 2025 polycystic ovary syndrome HITEC-Institute of Medical Sciences Completed No outcome recorded
Phase 1 NCT04177693 Nov 2020 → Jan 2022 leiomyoma Yale University Completed Missed primary
Phase 1 NCT03028532 Mar 2017 → Jan 2018 substance abuse Stuart Willick Completed No outcome recorded
Phase 1 NCT02448459 May 2015 → Mar 2016 infertility disorder University of Sao Paulo Completed No outcome recorded
Phase 1 NCT02024984 Nov 2013 → Jun 2014 polycystic ovary syndrome Ain Shams Maternity Hospital Unknown No outcome recorded
Phase 1 NCT01289756 Dec 2009 → Nov 2014 anovulation Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) Completed No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT01340521 Mar 1991 → Mar 1994 infertility disorder Milton S. Hershey Medical Center Completed No outcome recorded
Phase 29 trials
Phase 2 NCT04944836 Mar 2023 → Jul 2028 expected rotator cuff syndrome University of Utah Recruiting No outcome recorded
Phase 2 NCT05096169 May 2022 → Jan 2025 hypogonadism Weill Medical College of Cornell University Withdrawn No outcome recorded Stop: Enrollment
Phase 2 NCT03709849 Feb 2019 → Mar 2020 anovulation, hyperprolactinemia, menstrual disorder, ovarian dysfunction +1 Xiyuan Hospital of China Academy of Chinese Medical Sciences Unknown No outcome recorded
Phase 2 NCT02523898 Nov 2015 → Apr 2022 polycystic ovary syndrome Semnan University of Medical Sciences Terminated No outcome recorded
Phase 2 NCT03933618 Apr 2015 → Mar 2017 hypogonadism, male Albany Medical College Completed No outcome recorded
Phase 2 NCT01880086 Aug 2013 → Mar 2016 hypogonadism, male, male infertility, substance-related disorder Weill Medical College of Cornell University Completed No outcome recorded
Phase 2 NCT02274311 Jan 2011 → Oct 2014 acromegaly Felipe Henning Gaia Duarte Completed No outcome recorded
Phase 2 NCT01155518 Jun 2010 → Dec 2013 hypogonadotropic hypogonadism, type 2 diabetes mellitus State University of New York at Buffalo Terminated No outcome recorded Stop: Business
Phase 2 NCT00697814 Jun 2004 → Jun 2005 hypogonadotropic hypogonadism, prolactin-producing pituitary gland adenoma Federal University of São Paulo Completed No outcome recorded
Phase 2/32 trials
Phase 2/3 NCT03549741 Jul 2018 → Jun 2019 infertility disorder Assiut University Unknown No outcome recorded
Phase 2/3 NCT03770026 Jan 2018 → Jan 2019 anovulation Benha University Completed No outcome recorded
Phase 37 trials · 1 met primary
Phase 3 NCT03615547 Jan 2026 → Jan 2029 spermatogenic failure Hospices Civils de Lyon Withdrawn No outcome recorded
Phase 3 NCT07616973 May 2023 → May 2026 overdue female infertility Sana'a University Active not recruiting No outcome recorded
Phase 3 NCT06564961 Jul 2022 → Jun 2023 spermatogenic failure Shakeela Ishrat Completed No outcome recorded
Phase 3 NCT02732808 Sep 2014 → Apr 2016 female infertility Royan Institute Completed No outcome recorded
Phase 3 NCT02255578 Sep 2014 → Sep 2017 polycystic ovary syndrome Sheba Medical Center Unknown No outcome recorded
Phase 3 NCT01008319 Oct 2009 → Nov 2015 anovulation, ovarian dysfunction University of Oklahoma Completed No outcome recorded
Phase 3 NCT00068861 Nov 2002 → Feb 2006 female infertility, polycystic ovary syndrome, pregnancy disorder Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Completed Met primary
Phase 421 trials · 1 met primary · 1 missed
Phase 4 NCT07862725 Oct 2026 → Oct 2027 expected oligoasthenoteratozoospermia Hamad Medical Corporation Not yet recruiting No outcome recorded
Phase 4 NCT06701071 Jun 2025 → Jun 2028 expected female infertility University of Southern California Recruiting No outcome recorded
Phase 4 NCT07523022 Sep 2024 → Sep 2026 overdue male infertility Szeged University Enrolling by invitation No outcome recorded
Phase 4 NCT04157725 Jun 2023 → Jan 2025 infertility disorder, polycystic ovary syndrome American University of Beirut Medical Center Unknown No outcome recorded
Phase 4 NCT04983173 Nov 2021 → Mar 2026 infertility disorder Fundacion Dexeus Completed No outcome recorded
Phase 4 NCT05206448 Oct 2020 → Apr 2024 overdue infertility disorder, polycystic ovary syndrome Rachel Mejia Active not recruiting No outcome recorded
Phase 4 NCT03989024 Jul 2019 → Dec 2020 anovulation, infertility disorder, polycystic ovary syndrome RenJi Hospital Unknown No outcome recorded
Phase 4 NCT03400722 Dec 2017 → Aug 2018 female infertility, ovarian hyperstimulation syndrome Nova Clinic, Russia Unknown No outcome recorded
Phase 4 NCT03309436 Aug 2017 → Jun 2018 female infertility ShangHai Ji Ai Genetics & IVF Institute Unknown No outcome recorded
Phase 4 NCT02802865 Aug 2016 → May 2018 infertility disorder, polycystic ovary syndrome Rachel Mejia Completed Met primary
Phase not applicable19 trials · 1 met primary · 1 missed
— NCT04052607 Sep 2019 → Apr 2020 infertility disorder Ibn Sina Hospital Terminated No outcome recorded
— NCT04619914 Mar → Jul 2019 — Laylay Mohammed Khalleefah Alhibshi Completed No outcome recorded
— NCT03316469 Jul → Oct 2018 polycystic ovary syndrome Ain Shams University Unknown No outcome recorded
— NCT03178500 Feb 2017 → Jul 2018 polycystic ovary syndrome Ain Shams Maternity Hospital Unknown No outcome recorded
— NCT02775877 May 2016 → Jun 2019 female infertility Navy General Hospital, Beijing Unknown No outcome recorded
— NCT02647424 Dec 2015 → Dec 2017 infertility disorder, polycystic ovary syndrome The University of Hong Kong Unknown No outcome recorded
— NCT02377479 Mar 2015 → Mar 2017 infertility disorder University Hospitals Cleveland Medical Center Withdrawn No outcome recorded
— NCT01718444 Mar 2015 → Jun 2016 infertility disorder, polycystic ovary syndrome University of Illinois at Chicago Terminated No outcome recorded
— NCT02544776 Jan → Aug 2015 anovulation Ahmed Fathy Ali Mohamed Ghanem Completed No outcome recorded
— NCT02269306 Jan 2011 → Jan 2013 anovulation Menoufia Obstetrics and Gynecology Group Completed No outcome recorded
Comparator or background therapy87 trials
Phase 0 NCT03681197 Comparator Jun 2018 → Apr 2019 infertility disorder Elham Raafat Unknown No outcome recorded
Phase 0 NCT03566225 Comparator Jan 2018 → Feb 2021 — Ain Shams University Completed No outcome recorded
Phase 0 NCT01909141 Comparator Aug 2013 → Feb 2014 infertility disorder, polycystic ovary syndrome Cairo University Completed No outcome recorded
Phase 1 NCT03755037 Comparator Jan 2017 → Apr 2018 female infertility Nesreen Abdel Fattah Abdullah Shehata Completed No outcome recorded
Phase 1/2 NCT04916925 Background Aug → Sep 2021 letrozole toxicity, polycystic ovary syndrome, vitamin D deficiency Ain Shams University Unknown No outcome recorded

Press releases naming this drug 1 release

DateIssuerRelease
2023-10-03 Cosette Pharmaceuticals, Inc. Cosette Pharmaceuticals Partners With Mark Cuban Cost Plus Drug Company to Make CLOMID® More Affordable cosettepharma.com ↗

Evidence & citations 11 cited values

Every value below carries the sentence it was read from. 156 sources stand behind the page.

FieldValueCited text
Known as Clomiphene citrate “OBJECTIVE: To evaluate pregnancy rates with letrozole and clomiphene citrate (CC) alone for superovulation in an intrauterine insemination program for women with recently...” PMID 22181973 ↗ Jan 2012
122

“Clomiphene citrate (Ovumid®, Iran Hormones Company) 25 mg/day with co-treatment of Letrozole (Letrofem®, Iran Hormones Company) 2.5 mg/day are given from cycle day 3 onwards.” NCT02732808 ↗

“Following ovulation or no response to increasing clomiphene-citrate doses, correlations between predictors and treatment responses were analyzed.” PMID 26848057 ↗ Dec 2015

“Comparison of Micro-dose Human Chorionic Gonadotropin (hCG) With HMG in PCOs Patients With Previous Clomiphene Citrate (CC)-Resistant Anovulation” NCT00947713 ↗

“Letrozole Versus Combined Metformin and Clomiphene Citrate for Ovulation Induction in Clomiphene-Resistant Women With Polycystic Ovary Syndrome” NCT00911313 ↗

“Thirty PCOS patients treated with 3 cycles of 100mg/day of Clomid (clomiphene citrate) on days 3 to 7 following an initial provera withdrawal” NCT01607320 ↗

“Combined Metformin and Clomiphene Citrate (CC) or Laparoscopic Ovarian Diathermy for Women With CC Resistant Polycystic Ovary Syndrome (PCOS)” NCT00969631 ↗

“Clomiphene citrate, a selective estrogen-receptor modulator that antagonizes the negative feedback of estrogen at the hypothalamus” NCT04361175 ↗

“Clomiphene citrate is a well-established agent that has been empirically used in cases of idiopathic oligospermia.” PMID 16291975 ↗ Nov 2005

“Clomiphene citrate (CC) is a commonly prescribed pharmacologic agent used to induce ovulation in women with PCOS.” NCT06507332 ↗

“Clomiphene citrate 100mg (2 tablets clomid 50mg each per day,from 2nd to 6th day of the cycle ) will be added” NCT04010942 ↗

Show 112 more sources

Known as Clomid “All patients received 100 mg CC (Clomid®; Global Napi Pharmaceuticals, Cairo, Egypt) for 5 days starting from day 3 of spontaneous or induced menstruation.” NCT01157312 ↗
16

“induction of ovulation with clomiphene citrate (Clomid®, Aventis) 50 mg tablet twice daily starting from the third day of menstrual cycle and for 5 days” PMID 32363556 ↗ May 2020

“Clomid 50 mg per day will be administered orally and human chorionic gonadotrophin ( choriomon ) 5000 IU will be administered IM once per week.” NCT01529177 ↗

“Thirty PCOS patients treated with 3 cycles of 100mg/day of Clomid (clomiphene citrate) on days 3 to 7 following an initial provera withdrawal” NCT01607320 ↗

“Clomiphene citrate(Clomid; Aventis pharma S.AE, Global Napi pharmaceuticals, Cairo, Egypt) 100 mg/day is administered from cycle day 3 to 7.” NCT01232075 ↗

“100 mg clomiphene Citrate (Clomid , global Napi , Egypt) CC tablets taken from day 3 to day 7 of the cycle” NCT02562664 ↗

“patients in either group received 100 mg CC (Clomid®; Global Napi Pharmaceuticals,Cairo, Egypt)” NCT01008046 ↗

“Clomiphene citrate 50 mg tab oral tablets(Clomid 50 mg tablets Global Napi , Egypt)” NCT01212263 ↗

“Clomiphene citrate (Clomid) is often used for assisted reproductive technologies” NCT06701071 ↗

“Clomid is the standard first drug of treatment for ovulation induction” NCT01793038 ↗

“Clomiphene citrate (clomid) (50mg) will be given for 5 days” NCT03178500 ↗

Show 6 more sources

Known as Clomifene Citrate “clomifene citrate 50 mg three times daily” NCT04052607 ↗
5

NCT01389713 ↗

NCT02544776 ↗

NCT03615547 ↗

NCT00478504 ↗

NCT01791751 ↗

Known as clomiphen citrate “Initial clomiphen citrate (CC) doses were 50 mg daily for 5 days starting on cycle day 3.” NCT02269306 ↗
Known as clomiphene “100 mg clomiphene Citrate (Clomid , global Napi , Egypt) CC tablets taken from day 3 to day 7 of the cycle” NCT02562664 ↗
31

“Drug: Clomiphene” NCT01679574 ↗

NCT01155518 ↗

NCT02690870 ↗

NCT02294773 ↗

NCT02377479 ↗

NCT02137265 ↗

NCT01607320 ↗

NCT02274311 ↗

NCT01904734 ↗

NCT03989024 ↗

Show 21 more sources

Known as Omifin “CC 50 mg/day (Omifin®) + rFSH 150 IU (Ovaleap®)” NCT04983173 ↗
Known as Ovumid “Clomiphene citrate (Ovumid®, Iran Hormones Company) 25 mg/day with co-treatment of Letrozole (Letrofem®, Iran Hormones Company) 2.5 mg/day are given from cycle day 3 onwards.” NCT02732808 ↗
Known as Tecnovula “clomiphene citrate 50 mg (Tecnovula®)” NCT05753098 ↗
Action Activate “Traditionally, clomiphene citrate, an estrogen receptor agonist, is the most used drug for this type of anovulation.” NCT00427700 ↗
Modality Other / unclassified “Clomiphene citrate, a selective estrogen receptor modulator (SERM) oral medication which inhibits estrogen effects (feedback) on the brain” NCT01880086 ↗
Route Oral “oral clomiphene citrate daily” NCT00005104 ↗